Profile data is unavailable for this security.
About the company
Shenzhen YHLO Biotech Co Ltd is a China-based company principally engaged in the research and development, manufacture and sales of in-vitro diagnostic equipment and supporting reagents, as well as the agency sales of some non-self-produced medical device products. The Company's products are applied in autoimmunity, reproductive health, diabetes and infectious disease fields. The Company's main products include in-vitro diagnostic instruments and supporting reagents based on chemiluminescence, immunoblotting, enzyme-linked immunoassay, immunofluorescence chromatography and other methodologies. The Company distributes its products in domestic market and to overseas markets.
- Revenue in CNY (TTM)1.82bn
- Net income in CNY339.81m
- Incorporated2008
- Employees1.76k
- LocationShenzhen YHLO Biotech Co LtdNo. 65, Baolong 2nd RoadBaolong Neighbourhood, Longgang DistrictSHENZHEN 518116ChinaCHN
- Phone+86 75 584821649
- Fax+86 75 526473319
- Websitehttps://www.szyhlo.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sansure Biotech Inc | 1.20bn | 384.73m | 9.96bn | 2.01k | 26.26 | 1.33 | -- | 8.28 | 0.6448 | 0.6448 | 2.06 | 12.77 | 0.1377 | 0.8274 | 1.41 | 599,646.90 | 4.14 | 26.74 | 4.69 | 30.97 | 74.82 | 67.47 | 30.06 | 42.01 | 7.94 | -- | 0.0589 | 22.40 | -84.39 | 27.12 | -81.22 | 121.89 | 64.08 | -- |
Qingdao Haier Biomedical Co Ltd | 2.28bn | 406.15m | 11.36bn | 2.64k | 27.94 | 2.60 | -- | 4.98 | 1.28 | 1.28 | 7.19 | 13.72 | 0.4069 | 4.93 | 8.41 | 865,378.00 | 7.39 | 11.49 | 9.42 | 15.22 | 49.30 | 49.98 | 18.17 | 25.20 | 2.53 | -- | 0.0295 | 26.53 | -20.36 | 22.07 | -32.41 | 28.94 | 20.64 | -- |
Micro-Tech Nanjing Co Ltd | 2.48bn | 527.90m | 11.39bn | 2.40k | 21.57 | 3.05 | -- | 4.59 | 2.81 | 2.81 | 13.23 | 19.86 | 0.5948 | 1.62 | 6.91 | 1,032,216.00 | 12.91 | 10.74 | 14.98 | 12.82 | 64.81 | 63.04 | 21.71 | 19.37 | 5.19 | -- | 0.01 | 35.43 | 21.78 | 21.20 | 46.99 | 20.32 | 39.33 | -- |
Shanghai MicroPort Edvcl MdTch Grp CoLtd | 1.26bn | 551.89m | 12.74bn | 908.00 | 21.07 | 3.15 | -- | 10.11 | 4.91 | 4.91 | 11.27 | 32.80 | 0.3769 | 1.60 | 7.96 | 1,387,329.00 | 16.35 | 17.68 | 18.12 | 19.43 | 75.61 | 76.60 | 43.39 | 42.25 | 9.49 | -- | 0.008 | 44.46 | 32.43 | 38.72 | 37.98 | 40.28 | 50.18 | -- |
Shenzhen YHLO Biotech Co Ltd | 1.82bn | 339.81m | 12.80bn | 1.76k | 37.74 | 4.86 | -- | 7.01 | 0.5956 | 0.5956 | 3.21 | 4.62 | 0.4798 | 1.11 | 4.91 | 1,037,196.00 | 7.03 | 16.43 | 9.12 | 24.16 | 62.14 | 53.26 | 14.66 | 20.01 | 1.50 | -- | 0.1872 | 30.28 | -48.42 | 23.02 | -64.93 | 56.32 | 28.88 | -- |
Eyebright Medical Tchnlgy Beijing Co Ltd | 1.07bn | 328.48m | 13.42bn | 2.07k | 40.89 | 6.05 | -- | 12.52 | 1.73 | 1.73 | 5.64 | 11.69 | 0.4003 | 1.99 | 5.19 | 516,774.60 | 11.51 | 9.99 | 13.27 | 11.16 | 72.24 | 81.29 | 28.74 | 34.66 | 2.48 | -- | 0.1339 | 19.91 | 64.14 | 49.59 | 30.63 | 71.80 | 38.83 | -- |
Beijing Balance Medical Technolgy Co Ltd | 382.01m | 111.83m | 13.71bn | 473.00 | 123.53 | 11.36 | -- | 35.88 | 0.8125 | 0.8125 | 2.78 | 8.84 | 0.3061 | 1.06 | 5.72 | 807,636.20 | 8.16 | 8.06 | 8.48 | 8.40 | 89.40 | 89.41 | 26.67 | 30.02 | 9.77 | -- | 0.0094 | 69.19 | 25.57 | 27.35 | 21.09 | 28.10 | 125.94 | -- |
Data as of Jul 03 2024. Currency figures normalised to Shenzhen YHLO Biotech Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
E Fund Management Co., Ltd.as of 31 Dec 2023 | 25.84m | 9.65% |
Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 8.48m | 3.17% |
Changsheng Fund Management Co., Ltd.as of 31 Dec 2023 | 5.98m | 2.23% |
Morgan Stanley Huaxin Fund Management Co., Ltd.as of 31 Dec 2023 | 5.11m | 1.91% |
ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 3.60m | 1.35% |
Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 3.51m | 1.31% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 2.98m | 1.11% |
China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 2.95m | 1.10% |
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 2.36m | 0.88% |
Rongtong Fund Management Co., Ltd.as of 31 Dec 2023 | 2.00m | 0.75% |
More ▼
Data from 31 Dec 2023 - 27 Jun 2024Source: FactSet Research Systems Inc.